Cancer | Page 87 of 103 | SpiritIndia.com

Prostate Cancer :: Data on Genetic Susceptibility for Prostate Cancer

The National Cancer Institute (NCI), part of the National Institutes of Health, has released new data from the Cancer Genetic Markers of Susceptibility (CGEMS) study on prostate cancer. This information could help identify genetic factors that influence the disease and will be integral to the discovery and development of new, targeted therapies. This is also the first public release of a whole genome association study of cancer – such studies examine the entire genome, with no assumptions about which genetic alterations cause cancer.

Cancer :: Computer factories workers have more cancer risk

A person who works in the manufacturing of computers has a higher risk of dying of cancer, compared to other people, according to an article published in the journal Environmental Health. In fact, overall death rates (cancer and non cancer) are higher among computer manufacturing workers.

Cancer :: Taxotere, docetaxel by Sanofi-Aventis for Advanced Head and Neck Cancer

The Food and Drug Administration (FDA) approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN). This disease represents approximately 3 percent of all new cancer cases in the United States.

Breast Cancer :: Breast-cancer revelation not solely limited to detecting lumps

Women should be aware that not every type of breast cancer reveals itself with a lump during self exams. An aggressive, fast-spreading form called inflammatory breast cancer (IBC) grows in nests or sheets of cancer cells that spread through the breast. Because it is relatively rare, IBC is often diagnosed late or even misdiagnosed as an infection.

Breast Cancer :: Mammograms reduce breast cancer deaths, but increase overdiagnosis

A new review of studies offers good news and bad news for women faced with the decision about whether to get regular mammograms. The good news is that screening mammography does reduce breast cancer mortality. The review found that women offered screening mammograms are 15 percent less likely to die of breast cancer than women who are not offered mammograms.

Cancer :: Cancer stem cells linked to radiation resistance

Certain types of brain cancer cells, called cancer stem cells, help brain tumors to buffer themselves against radiation treatment by activating a “repair switch” that enables them to continue to grow unchecked, researchers at Duke University Medical Center have found.

Cancer :: Berkeley cancer genome center to study tumor genomics

The newly established Berkeley Cancer Genome Center, led by members of the Life Sciences Division in the Department of Energy’s Lawrence Berkeley National Laboratory, is one of seven Cancer Genome Characterization Centers to receive awards from the National Cancer Institute and the National Human Genome Research Institute. Earlier today the two institutes, both part of the National Institutes of Health, announced a three-year, $35 million project which will seek to identify important genetic changes involved in lung, brain, and ovarian cancers through genome analysis.

Cancer :: Methoxyamine – new cancer therapy reverses resistance to chemotherapy

Case Western Reserve University’s Technology Transfer Office has entered a worldwide exclusive licensing agreement with TRACON Pharmaceuticals of San Diego, Calif., to develop Methoxyamine, a new cancer therapeutic that reverses cancer cell resistance to chemotherapy. Methoxyamine is a “first in class” drug that targets a specific DNA repair pathway.

Lung Cancer :: Key to lung cancer chemotherapy resistance revealed

Scientists at Johns Hopkins have discovered how taking the brakes off a ?detox? gene causes chemotherapy resistance in a common form of lung cancer. Products made by a gene called NRF2 normally protect cells from environmental pollutants like cigarette smoke and diesel exhaust by absorbing the materials and pumping them out of the cell. Another gene called KEAP1 encodes products that stop this cleansing process. But lung cancer cells sabotage the expression of these same genes to block assault from chemotherapy drugs.

Prostate Cancer :: Prostate Cancer Among African American Men

Bethesda, Md. ? Researchers from 12 institutions, including the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced the results of the first genome-wide linkage study of prostate cancer in African Americans. Using genetic markers, researchers identified several regions of the human genome that likely contain genes that, when altered, increase the risk of developing prostate cancer.